comparemela.com

Latest Breaking News On - Novaccess global inc view - Page 2 : comparemela.com

NovAccess Global Inc : Dr Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award

Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon AwardCLEVELAND, OH / ACCESSWIRE / March 15, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing

United statesSanta cruz divisionDennis riedlDwain irvinLos angelesChristopher wheelerUniversity of californiaSecurities exchange commissionDepartment of chemistry biochemistryDarrow associatesWorld orphan drug congressNovaccess global inc viewWorld brain mapping foundationVaccine manufacturing laboratoryWorld brain mapping foundation annual congressSinai medical center department of neurosurgery

NovAccess Global Inc : NovAccess Global to Present at World Orphan Drug Congress

CLEVELAND, OH / ACCESSWIRE / February 16, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced that its CEO Dr. Dwain

United statesDennis riedlDwain irvinChristopher wheelerSecurities exchange commissionDarrow associatesDrug administrationWorld orphan drug congressNovaccess global inc viewSecurities exchangeOffice of orphan products developmentOur companyStemvax therapeutics incNovaccess global incNovaccess globalAccess global

NovAccess Global Inc : NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress

Dr. Christopher Wheeler, NovAccess Lead Scientist, to Receive Leadership Award for his ContributionsCLEVELAND, OH / ACCESSWIRE / February 3, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company

United statesSanta cruz divisionDwain irvinLos angelesSchwierige zeitenChristopher wheelerUniversity of californiaSecurities exchange commissionDepartment of chemistry biochemistryDarrow associatesNovaccess global inc viewWorld brain mapping foundationVaccine manufacturing laboratoryWorld brain mapping foundation annual congressSociety for brain mapping therapeuticsSinai medical center department of neurosurgery

NovAccess Global Inc : NovAccess Global Announces Fireside Chat with Dr Christopher Wheeler, the Company s Lead Scientist and President of its StemVax Therapeutics Division

Topic: Immunotherapy Advantages Over Surgical TreatmentCLEVELAND, OH / ACCESSWIRE / January 5, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain

Cori freemanDwain irvinJ kyle moyerChristopher wheelerSecurities exchange commissionCompany board of directorsDarrow associatesDrug administrationNovaccess global inc viewVaccine manufacturing laboratorySecurities exchangeSinai medical center department of neurosurgeryOur companyStemvax therapeutics incNovaccess global incNovaccess global

NovAccess Global Inc : NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate

Topic: Benefits of Immunotherapies Versus Conventional Chemotherapy for Patients and Their Support NetworksCLEVELAND, OH / ACCESSWIRE / November 22, 2022 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical

Cori freemanDwain irvinChristopher wheelerSecurities exchange commissionCompany board of directorsDarrow associatesNovaccess global inc viewTheir support networksSecurities exchangeOur companyStemvax therapeutics incNovaccess global incTheir supportNovaccess globalAccess globalOrphan drug

vimarsana © 2020. All Rights Reserved.